{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:45:41Z","timestamp":1789062341264,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.prro.2023.04.009","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T06:07:04Z","timestamp":1683698824000},"page":"e400-e408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Decision Regret and Bother With the Addition of Androgen Deprivation Therapy to Definitive Radiation Treatment for Localized Prostate Cancer"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3155-5394","authenticated-orcid":false,"given":"Victoria","family":"Booth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Lieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryana","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kneebone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2023.04.009_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","article-title":"Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: An individual patient data meta-analysis","volume":"23","author":"Kishan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0002","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2015.64.8055","article-title":"Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: Results of EORTC Trial 22991","volume":"34","author":"Bolla","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0003","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijrobp.2020.06.011","article-title":"Absolute versus relative benefit of androgen deprivation therapy for prostate cancer: Moving beyond the hazard ratio to personalize therapy","volume":"108","author":"Spratt","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0004","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2023.04.009_bib0005","doi-asserted-by":"crossref","first-page":"e13076","DOI":"10.1111\/ecc.13076","article-title":"Health-related quality of life in long-term survivors with localised prostate cancer by therapy\u2014Results from a population-based study","volume":"28","author":"Adam","year":"2019","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.prro.2023.04.009_bib0006","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(18)30780-0","article-title":"Quality of life in men living with advanced and localised prostate cancer in the UK: A population-based study","volume":"20","author":"Downing","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0007","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/cen.13249","article-title":"Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy","volume":"86","author":"Cheung","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.prro.2023.04.009_bib0008","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijrobp.2016.11.002","article-title":"Effect of long-term hormonal therapy (vs short-term hormonal therapy): A secondary analysis of intermediate-risk prostate cancer patients treated on NRG oncology RTOG 9202","volume":"97","author":"Mirhadi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.04.009_bib0009","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","article-title":"High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01\/05 GICOR): A randomised, controlled, phase 3 trial","volume":"16","author":"Zapatero","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0010","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/j.prro.2021.09.008","article-title":"Early outcomes and decision regret using PSMA\/MRI-guided focal boost for prostate cancer SBRT","volume":"12","author":"Eade","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2023.04.009_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X03256005","article-title":"Validation of a decision regret scale","volume":"23","author":"Brehaut","year":"2003","journal-title":"Med Decis Making"},{"key":"10.1016\/j.prro.2023.04.009_bib0013","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2003.02.115","article-title":"Patients\u2019 perceptions of quality of life after treatment for early prostate cancer","volume":"21","author":"Clark","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.euo.2018.12.004","article-title":"Patient-reported outcomes following treatment of localised prostate cancer and their association with regret about treatment choices","volume":"3","author":"van Stam","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0017","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/cncr.28563","article-title":"Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment","volume":"120","author":"Resnick","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2023.04.009_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1467-9280.00228","article-title":"Misremembrance of options past: Source monitoring and choice","volume":"11","author":"Mather","year":"2000","journal-title":"Psychol Sci"},{"key":"10.1016\/j.prro.2023.04.009_bib0019","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1464-410X.2011.10475.x","article-title":"Information needs of men on androgen deprivation therapy","volume":"109","author":"Soeyonggo","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.prro.2023.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdi370","article-title":"Patients\u2019 preferences for adjuvant chemotherapy in early breast cancer: What makes AC and CMF worthwhile now?","volume":"16","author":"Duric","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0021","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/ajco.12872","article-title":"68 Ga-PSMA-PET\/CT staging prior to definitive radiation treatment for prostate cancer","volume":"14","author":"Hruby","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.009_bib0022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1539-6053.2008.00033.x","article-title":"Helping doctors and patients make sense of health statistics","volume":"8","author":"Gigerenzer","year":"2007","journal-title":"Psychol Sci Public Interest"}],"updated-by":[{"DOI":"10.1016\/j.prro.2023.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000}}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850023001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850023001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T05:40:13Z","timestamp":1708753213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850023001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1879850023001169"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2023.04.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.prro.2023.12.001","asserted-by":"object"}]},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decision Regret and Bother With the Addition of Androgen Deprivation Therapy to Definitive Radiation Treatment for Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2023.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}